Gene trapping uncovers sex-specific mechanisms for upstream stimulatory factors 1 and 2 in angiotensinogen expression

Hypertension

Volumn 59, Issue 6, 2012, Pages 1212-1219

  Park, Sungmi ^a   Liu, Xuebo ^a   Davis, Deborah R ^a   Sigmund, Curt D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Adenovirus; Hypertension; Polymorphism; Short hairpin RNA; Transcription

Indexed keywords

ANGIOTENSINOGEN; MESSENGER RNA; SHORT HAIRPIN RNA; UPSTREAM STIMULATORY FACTOR 1; UPSTREAM STIMULATORY FACTOR 2;

ALLELE; ANIMAL EXPERIMENT; ARTICLE; BRAIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; FEMALE; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; IN VIVO STUDY; KIDNEY; LIPID DIET; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TRANSGENE;

ANGIOTENSINOGEN; ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; CHROMATIN IMMUNOPRECIPITATION; DIET, HIGH-FAT; DIETARY FATS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYPERTENSION; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA INTERFERENCE; SEX FACTORS; UPSTREAM STIMULATORY FACTORS;

EID: 84861532238     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.192971     Document Type: Article

References (40)

1. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, Smithies O. Genetic-control of blood-pressure and the angiotensinogen locus. Proc Natl Acad Sci USA. 1995;92:2735-2739.
2. Gardes J, Bouhnik J, Clauser E, Corvol P, Menard J. Role of angiotensinogen in blood-pressure homeostasis. Hypertension. 1982;4: 185-189.
3. Menard J, Elamrani AIK, Savoie F, Bouhnik J. Angiotensinogen: an attractive and underrated participant in hypertension and inflammation. Hypertension. 1991;18:705-706.
4. Dickson ME, Sigmund CD. Genetic basis of hypertension: revisiting angiotensinogen. Hypertension. 2006;48:14-20.
5. Dickson ME, Zimmerman MB, Rahmouni K, Sigmund CD. The-20 and-217 promoter variants dominate differential angiotensinogen haplotype regulation in angiotensinogen-expressing cells. Hypertension. 2007;49:631-639.
6. Grobe JL, Dickson ME, Park S, Davis DR, Born EJ, Sigmund CD. Cardiovascular consequences of genetic variation at-6/235 in human angiotensinogen using "humanized" gene-targeted mice. Hypertension. 2010;56:981-987.
7. Tiago AD, Samani NJ, Candy GP, Brooksbank R, Libhaber EN, Sareli P, Woodiwiss AJ, Norton GR. Angiotensinogen gene promoter region variant modifies body size-ambulatory blood pressure relations in hypertension. Circulation. 2002;106:1483-1487.
8. Hopkins PN, Heiss G, Ellison RC, Province MA, Pankow JS, Eckfeldt JH, Hunt SC. Coronary artery disease risk in familial combined: hyperlipidemia and familial hypertriglyceridemia-a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation. 2003;108:519-523.
9. Coon H, Xin YP, Hopkins PN, Cawthon RM, Hasstedt SJ, Hunt SC. Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides. Hum Genet. 2005;117: 444-451.
10. Hilgers KF, Veelken R, Muller DN, Kohler H, Hartner A, Botkin SR, Stumpf C, Schmieder RE, Gomez RA. Renin uptake by the endothelium mediates vascular angiotensin formation. Hypertension. 2001;38: 243-248.
11. Dickson ME, Tian X, Liu XB, Davis DR, Sigmund CD. Upstream stimulatory factor is required for human angiotensinogen expression and differential regulation by the A-20C polymorphism. Circ Res. 2008;103: 940-947.
12. Sarzani R, Bordicchia M, Marcucci P, Minardi D, Muzzonigro G, Dessi-Fulgheri P, Rappelli A. Angiotensinogen promoter variants influence gene expression in human kidney and visceral adipose tissue. J Hum Hypertens. 2010;24:213-219.
13. Komulainen K, Alanne M, Auro K, Kilpikari R, Pajukanta P, Saarela J, Ellonen P, Salminen K, Kulathinal S, Kuulasmaa K, Silander K, Salomaa V, Perola M, Peltonen L. Risk alleles of USF1 gene predict cardiovascular disease of women in two prospective studies. Plos Genetics. 2006;2:672-681.
14. West AG, Huang SM, Gaszner M, Litt MD, Felsenfeld G. Recruitment of histione modifications by USF proteins at a vertebrate barrier element. Mol Cell. 2004;16:453-463.
15. Huang S, Li X, Yusufzai TM, Qiu Y, Felsenfeld G. USF1 recruits histone modification complexes and is critical for maintenance of a chromatin barrier. Mol Cell Biol. 2007;27:7991-8002.
16. Sirito M, Lin Q, Maity T, Sawadogo M. Ubiquitous expression of the 43-kDa and 44-kDa forms of transcription factor Usf in mammalian-cells. Nucleic Acids Res. 1994;22:427-433.
17. Casado M, Vallet VS, Kahn A, Vaulont S. Essential role in vivo of upstream stimulatory factors for a normal dietary response of the fatty acid synthase gene in the liver. J Biol Chem. 1999;274:2009-2013.
18. Yang G, Merrill DC, Thompson MW, Robillard JE, Sigmund CD. Functional expression of the human angiotensinogen gene in transgenic mice. J Biol Chem. 1994;269:32497-32502.
19. Sinn PL, Davis DR, Sigmund CD. Highly regulated cell type-restricted expression of human renin in mice containing 140-or 160-kilobase pair P1 phage artificial chromosome transgenes. J Biol Chem. 1999;274: 35785-35793.
20. Lin Q, Luo X, Sawadogo M. Archaic structure of the gene encoding transcription factor Usf. J Biol Chem. 1994;269:23894-23903.
21. Hatae T, Takimoto E, Murakami K, Fukamizu A. Comparative studies on species-specific reactivity between renin and angiotensinogen. Mol Cell Biochem. 1994;131:43-47.
22. Wong RHF, Chang I, Hudak CSS, Hyun S, Kwan HY, Sul HS. A role of DNA-PK for the metabolic gene regulation in response to insulin. Cell. 2009;136:1056-1072.
23. Muse GW, Gilchrist DA, Nechaev S, Shah R, Parker JS, Grissom SF, Zeitlinger J, Adelman K. RNA polymerase is poised for activation across the genome. Nat Genet. 2007;39:1507-1511.
24. Viollet B, LefrancoisMartinez AM, Henrion A, Kahn A, Raymondjean M, Martinez A. Immunochemical characterization and transacting properties of upstream stimulatory factor isoforms. J Biol Chem. 1996;271: 1405-1415.
25. Vallet VS, Henrion AA, Bucchini D, Casado M, Raymondjean M, Kahn A, Vaulont S. Glucose-dependent liver gene expression in upstream stimulatory factor 2/mice. J Biol Chem. 1997;272:21944-21949.
26. Vallet VS, Casado M, Henrion AA, Bucchini D, Raymondjean M, Kahn A, Vaulont S. Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose. J Biol Chem. 1998;273:20175-20179.
27. Wu S, Mar-Heyming R, Dugum EZ, Kolaitis NA, Qi H, Pajukanta P, Castellani LW, Lusis AJ, Drake TA. Upstream transcription factor 1 influences plasma lipid and metabolic traits in mice. Hum Mol Genet. 2010;19:597-608.
28. Holzapfel C, Baumert J, Grallert H, Muller AM, Thorand B, Khuseyinova N, Herder C, Meisinger C, Hauner H, Wichmann HE, Koenig W, Illig T, Klopp N. Genetic variants in the USF1 gene are associated with lowdensity lipoprotein cholesterol levels and incident type 2 diabetes mellitus in women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Eur J Endocrinol. 2008;159:407-416.
29. Pajukanta P, Lilja HE, Sinsheimer JS, Cantor RM, Lusis AJ, Gentile M, Duan XQJ, Soro-Paavonen A, Naukkarinen J, Saarela J, Laakso M, Ehnholm C, Taskinen MR, Peltonen L. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet. 2004;36:371-376.
30. Stavreus-Evers A, Parini P, Freyschuss B, Elger W, Reddersen G, Sahlin L, Eriksson H. Estrogenic influence on the regulation of hepatic estrogen receptor-αand serum level of angiotensinogen in female rats. J Steroid Biochem Mol Biol. 2001;78:83-88.
31. Ding Y, Stec DE, Sigmund CD. Genetic evidence that lethality in angiotensinogen-deficient mice is due to loss of systemic but not renal angiotensinogen. J Biol Chem. 2001;276:7431-7436.
32. Morgan L, Crawshaw S, Baker PN, Broughton PF, Kalsheker N. Polymorphism in oestrogen response element associated with variation in plasma angiotensinogen concentrations in healthy pregnant women. J Hypertens. 2000;18:553-557.
33. Narayanan CS, Cui Y, Zhao YY, Zhou J, Kumar A. Orphan receptor Arp-1 binds to the nucleotide sequence located between TATA box and transcriptional initiation site of the human angiotensinogen gene and reduces estrogen induced promoter activity. Mol Cell Endocrinol. 1999;148:79-86.
34. Naukkarinen J, Gentile M, Soro-Paavonen A, Saarela J, Koistinen HA, Pajukanta P, Taskinen MR, Peltonen L. USF1 and dyslipidemias: converging evidence for a functional intronic variant. Hum Mol Genet. 2005;14:2595-2605.
35. Batifoulier-Yiannikouris F, Karounos M, Charnigo R, English VL, Rateri DL, Daugherty A, Cassis LA. Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice. Am J Physiol Regul Integr Comp Physiol. 2012; 302:R244-R251.
36. Yanai K, Saito T, Kakinuma Y, Kon Y, Hirota K, Taniguchi-Yanai K, Nishijo N, Shigematsu Y, Horiguchi H, Kasuya Y, Sugiyama F, Yagami K, Murakami K, Fukamizu A. Renin-dependent cardiovascular functions and renin-independent blood-brain barrier functions revealed by renindeficient mice. J Biol Chem. 2000;275:5-8.
37. Maeda K, Hata R, Bader M, Walther T, Hossmann KA. Larger anastomoses in angiotensinogen-knockout mice attenuate early metabolic disturbances after middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1999;19:1092-1098.
38. Xiao HD, Fuchs S, Frenzel K, Cole JM, Bernstein KE. Newer approaches to genetic modeling in mice: tissue-specific protein expression as studied using angiotensin-converting enzyme (ACE). Am J Pathol. 2003;163: 807-817.
39. Oliverio MI, Madsen K, Best CF, Ito M, Maeda N, Smithies O, Coffman TM. Renal growth and development in mice lacking AT1A receptors for angiotensin II. Am J Physiol. 1998;274:F43-F50.
40. Rada-Iglesias A, Ameur A, Kapranov P, Enroth S, Komorowski J, Gingeras TR, Wadelius C. Whole-genome maps of USF1 and USF2 binding and histone H3 acetylation reveal new aspects of promoter structure and candidate genes for common human disorders. Genome Res. 2008;18:380-392.